Advance in photosensitizers and light delivery for photodynamic therapy

346Citations
Citations of this article
458Readers
Mendeley users who have this article in their library.

Abstract

The brief history of photodynamic therapy (PDT) research has been focused on photosensitizers (PSs) and light delivery was introduced recently. The appropriate PSs were developed from the first generation PS Photofrin (QLT) to the second (chlorins or bacteriochlorins derivatives) and third (conjugated PSs on carrier) generations PSs to overcome undesired disadvantages, and to increase selective tumor accumulation and excellent targeting. For the synthesis of new chlorin PSs chlorophyll a is isolated from natural plants or algae, and converted to methyl pheophorbide a (MPa) as an important starting material for further synthesis. MPa has various active functional groups easily modified for the preparation of different kinds of PSs, such as methyl pyropheophorbide a, purpurin-18, purpurinimide, and chlorin e6 derivatives. Combination therapy, such as chemotherapy and photothermal therapy with PDT, is shortly described here. Advanced light delivery system is shown to establish successful clinical applications of PDT. Phtodynamic efficiency of the PSs with light delivery was investigated in vitro and/or in vivo. © 2013 Korean Society of Gastrointestinal Endoscopy.

Cite

CITATION STYLE

APA

Yoon, I., Li, J. Z., & Shim, Y. K. (2013). Advance in photosensitizers and light delivery for photodynamic therapy. Clinical Endoscopy, 46(1), 7–23. https://doi.org/10.5946/ce.2013.46.1.7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free